{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T20:23:21Z","timestamp":1785788601616,"version":"3.56.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,3]]},"DOI":"10.7759\/cureus.113892","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:29:50Z","timestamp":1785785390000},"source":"Crossref","is-referenced-by-count":0,"title":["Impact of Hypertensive Heart Disease on Coronary Artery Disease Severity Assessed by the Duke Coronary Artery Disease Index"],"prefix":"10.7759","author":[{"given":"Fahrudin","family":"Sabanovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farisa","family":"Babic Sabanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emir","family":"Becirovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Be\u0107irovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragan","family":"Piljic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh TA","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, et al.. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021, 42:3599-726. 10.1093\/eurheartj\/ehab368","journal-title":"Eur Heart J"},{"key":"ref2","doi-asserted-by":"crossref","DOI":"10.1016\/j.echo.2016.01.011","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"29","author":"Nagueh SF","year":"2016","unstructured":"Nagueh SF, Smiseth OA, Appleton CP, et al.. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2016, 29:277-314.","journal-title":"J Am Soc Echocardiogr"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac393","article-title":"Phenotyping the hypertensive heart","volume":"43","author":"Tadic M","year":"2022","unstructured":"Tadic M, Cuspidi C, Marwick TH. Phenotyping the hypertensive heart. Eur Heart J. 2022, 43:3794-810. 10.1093\/eurheartj\/ehac393","journal-title":"Eur Heart J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000207","article-title":"Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension","volume":"131","author":"Rosendorff C","year":"2015","unstructured":"Rosendorff C, Lackland DT, Allison M, et al.. Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension. Circulation. 2015, 131:435-70. 10.1161\/CIR.0000000000000207","journal-title":"Circulation"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252413294","article-title":"Systemic and cardiac microvascular dysfunction in hypertension","volume":"25","author":"Durante A","year":"2024","unstructured":"Durante A, Mazzapicchi A, Baiardo Redaelli M. Systemic and cardiac microvascular dysfunction in hypertension. Int J Mol Sci. 2024, 25:13294. 10.3390\/ijms252413294","journal-title":"Int J Mol Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000002910","article-title":"Hypertension and heart failure with preserved ejection fraction: position paper by the European Society of Hypertension","volume":"39","author":"Kasiakogias A","year":"2021","unstructured":"Kasiakogias A, Rosei EA, Camafort M, et al.. Hypertension and heart failure with preserved ejection fraction: position paper by the European Society of Hypertension. J Hypertens. 2021, 39:1522-45. 10.1097\/HJH.0000000000002910","journal-title":"J Hypertens"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12175723","article-title":"Hypertensive heart disease: a narrative review series-part 2: macrostructural and functional abnormalities","volume":"12","author":"Nemtsova V","year":"2023","unstructured":"Nemtsova V, Burkard T, Vischer AS. Hypertensive heart disease: a narrative review series-part 2: macrostructural and functional abnormalities. J Clin Med. 2023, 12:5723. 10.3390\/jcm12175723","journal-title":"J Clin Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcvp\/pvae084","article-title":"2024 ESC guidelines for the management of elevated blood pressure and hypertension: what is new in pharmacotherapy?","volume":"11","author":"McCarthy CP","year":"2025","unstructured":"McCarthy CP, Bruno RM, McEvoy JW, Touyz RM. 2024 ESC guidelines for the management of elevated blood pressure and hypertension: what is new in pharmacotherapy?. Eur Heart J Cardiovasc Pharmacother. 2025, 11:7-9. 10.1093\/ehjcvp\/pvae084","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"ref9","article-title":"Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","year":"2018","unstructured":"Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017. a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018, 392:1859-922.","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.59497","article-title":"Racial and socioeconomic determinants of cardiovascular health: a comprehensive review","volume":"16","author":"Borkowski P","year":"2024","unstructured":"Borkowski P, Borkowska N, Mangeshkar S, Adal BH, Singh N. Racial and socioeconomic determinants of cardiovascular health: a comprehensive review. Cureus. 2024, 16:59497. 10.7759\/cureus.59497","journal-title":"Cureus"},{"key":"ref11","doi-asserted-by":"crossref","DOI":"10.1038\/nrcardio.2011.154","article-title":"Cardiac remodeling at the population level\u2014risk factors, screening, and outcomes","volume":"8","author":"Gjesdal O","year":"2011","unstructured":"Gjesdal O, Bluemke DA, Lima JA. Cardiac remodeling at the population level\u2014risk factors, screening, and outcomes. Nat Rev Cardiol. 2011, 8:673-85.","journal-title":"Nat Rev Cardiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.20471\/acc.2024.63.03-04.25","article-title":"The rheological properties of the carotid circulation in metabolic syndrome patients with and without diabetes","volume":"63","author":"Hajdarevi\u0107 A","year":"2024","unstructured":"Hajdarevi\u0107 A, Pilji\u0107 D, \u0160abanovi\u0107 F, Pilji\u0107 D, Babi\u0107 F, Beganovi\u0107 A, K\u0161ela J. The rheological properties of the carotid circulation in metabolic syndrome patients with and without diabetes. Acta Clin Croat. 2024, 63:656-61. 10.20471\/acc.2024.63.03-04.25","journal-title":"Acta Clin Croat"},{"key":"ref13","doi-asserted-by":"crossref","DOI":"10.1016\/S0735-1097(01)01663-1","article-title":"Left ventricular mass and cardiovascular morbidity in essential hypertension: the MAVI study","volume":"38","author":"Verdecchia P","year":"2001","unstructured":"Verdecchia P, Carini G, Circo A, et al.. Left ventricular mass and cardiovascular morbidity in essential hypertension: the MAVI study. J Am Coll Cardiol. 2001, 38:1829-35.","journal-title":"J Am Coll Cardiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/ehjci\/jev076","article-title":"Recommendations on the use of echocardiography in adult hypertension: a report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE)\u2020","volume":"16","author":"Marwick TH","year":"2015","unstructured":"Marwick TH, Gillebert TC, Aurigemma G, et al.. Recommendations on the use of echocardiography in adult hypertension: a report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE)\u2020. Eur Heart J Cardiovasc Imaging. 2015, 16:577-605. 10.1093\/ehjci\/jev076","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.89.5.2015","article-title":"Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty","volume":"89","author":"Mark DB","year":"1994","unstructured":"Mark DB, Nelson CL, Califf RM, et al.. Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty. Circulation. 1994, 89:2015-25. 10.1161\/01.cir.89.5.2015","journal-title":"Circulation"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/medicina60050765","article-title":"Coronary computed tomography angiography-derived modified Duke index is associated with peri-coronary fat attenuation index and predicts severity of coronary inflammation","volume":"60","author":"Hala\u021biu VB","year":"2024","unstructured":"Hala\u021biu VB, Benedek I, Rodean IP, et al.. Coronary computed tomography angiography-derived modified Duke index is associated with peri-coronary fat attenuation index and predicts severity of coronary inflammation. Medicina (Kaunas). 2024, 60:765. 10.3390\/medicina60050765","journal-title":"Medicina (Kaunas)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.112.001264","article-title":"Long-term survival and repeat coronary revascularization in dialysis patients after surgical and percutaneous coronary revascularization with drug-eluting and bare metal stents in the United States","volume":"127","author":"Shroff GR","year":"2013","unstructured":"Shroff GR, Solid CA, Herzog CA. Long-term survival and repeat coronary revascularization in dialysis patients after surgical and percutaneous coronary revascularization with drug-eluting and bare metal stents in the United States. Circulation. 2013, 127:1861-9. 10.1161\/CIRCULATIONAHA.112.001264","journal-title":"Circulation"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.675722","article-title":"Real-world outcomes of revascularization strategies in patients with left ventricular dysfunction and three-vessel coronary disease stratified by mitral regurgitation","volume":"8","author":"Fan Q","year":"2021","unstructured":"Fan Q, Liu J, Xu Y, et al.. Real-world outcomes of revascularization strategies in patients with left ventricular dysfunction and three-vessel coronary disease stratified by mitral regurgitation. Front Cardiovasc Med. 2021, 8:675722. 10.3389\/fcvm.2021.675722","journal-title":"Front Cardiovasc Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2019.0014","article-title":"Baseline characteristics and risk profiles of participants in the ischemia randomized clinical trial","volume":"4","author":"Hochman JS","year":"2019","unstructured":"Hochman JS, Reynolds HR, Bangalore S, et al.. Baseline characteristics and risk profiles of participants in the ischemia randomized clinical trial. JAMA Cardiol. 2019, 4:273-86. 10.1001\/jamacardio.2019.0014","journal-title":"JAMA Cardiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1915922","article-title":"Initial invasive or conservative strategy for stable coronary disease","volume":"382","author":"Maron DJ","year":"2020","unstructured":"Maron DJ, Hochman JS, Reynolds HR, et al.. Initial invasive or conservative strategy for stable coronary disease. N Engl J Med. 2020, 382:1395-407. 10.1056\/NEJMoa1915922","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/517486-impact-of-hypertensive-heart-disease-on-coronary-artery-disease-severity-assessed-by-the-duke-coronary-artery-disease-index","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:29:51Z","timestamp":1785785391000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/517486-impact-of-hypertensive-heart-disease-on-coronary-artery-disease-severity-assessed-by-the-duke-coronary-artery-disease-index"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,3]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.113892","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,3]]}}}